Effects of simvastatin and atorvastatin administration on insulin resistance and respiratory quotient in aged dyslipidemic non-insulin dependent diabetic patients

被引:137
作者
Paolisso, G
Barbagallo, M
Petrella, G
Ragno, E
Barbieri, M
Giordano, M
Varricchio, M
机构
[1] Univ Naples 2, Serv Astanteria Med, Dept Geriatr Med & Metab Dis, I-80138 Naples, Italy
[2] Univ Catania, Inst Internal Med & Geriatr Med, Catania, Italy
关键词
statins; insulin resistance; respiratory quotient; glycosylated haemoglobin; non-insulin dependent diabetes mellitus;
D O I
10.1016/S0021-9150(99)00352-4
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
One hundred and ninety-five aged (mean age: 67 +/- 4.8 years), non-insulin dependent diabetic patients underwent a randomised single-blind study for investigating the effect of statin administration on insulin resistance and respiratory quotient. After 4 weeks run-in period, all patients were randomised in three groups: placebo (n = 67), simvastatin (10 mg/day) (n = 61) and atorvastatin (5 mg/day) (n = 67). Each treatment period lasted 8 weeks. At the beginning, after the run-in and at the end of the study, insulin resistance was assessed by homeostasis model assessment (HOMA) index, while respiratory quotient (Rq) was evaluated by indirect calorimetry. Statins versus placebo significantly lowered plasma total, LDL-, HDL-cholesterol and triglyceride concentrations and improved insulin resistance and Rq and metabolic control. Atorvastatin had a greater effect than simvastatin on plasma triglyceride concentration (- 26.3 +/- 3.1 vs. - 19.7 +/- 2.8%, P < 0.03), HOMA index (- 13.1 +/- 0.6 vs. - 9.1 +/- 0.9%, P<0.05), Rq (5.9 +/- 0.4 vs. 3.1 +/- 0.5%, P < 0.05) and glycosylated haemoglobin ( - 11.2 +/- 0.3 vs. - 7.1 +/- 0.4%, P < 0.05). In the whole group of subjects (n = 195) and at the end of the study, changes in plasma triglyceride concentrations were significantly correlated with the change in the HOMA index (r = 0.44, P<0.001) and age and BMI adjusted-Rq (r = - 0.32, P < 0.005). Multivariate analyses demonstrated that decline in plasma triglyceride concentration was a significant determinant for explaining the effect of statin on insulin resistance and Rq. In conclusion our study demonstrates that statin administration is useful for controlling dyslipidemia in NIDDM patients and for improving the metabolic control. With regard to this latter aim, atorvastatin seems to be more powerful than simvastatin. (C) 2000 Elsevier Science Ireland Ltd. All rights reserved.
引用
收藏
页码:121 / 127
页数:7
相关论文
共 40 条
[1]   Metabolic modes of action of the statins in the hyperlipoproteinemias [J].
Aguilar-Salinas, CA ;
Barrett, H ;
Schonfeld, G .
ATHEROSCLEROSIS, 1998, 141 (02) :203-207
[2]   BODY-FAT DISTRIBUTION, PLASMA-LIPIDS, AND LIPOPROTEINS [J].
ANDERSON, AJ ;
SOBOCINSKI, KA ;
FREEDMAN, DS ;
BARBORIAK, JJ ;
RIMM, AA ;
GRUCHOW, HW .
ARTERIOSCLEROSIS, 1988, 8 (01) :88-94
[3]   REGRESSION OF CORONARY-ARTERY DISEASE AS A RESULT OF INTENSIVE LIPID-LOWERING THERAPY IN MEN WITH HIGH-LEVELS OF APOLIPOPROTEIN-B [J].
BROWN, G ;
ALBERS, JJ ;
FISHER, LD ;
SCHAEFER, SM ;
LIN, JT ;
KAPLAN, C ;
ZHAO, XQ ;
BISSON, BD ;
FITZPATRICK, VF ;
DODGE, HT .
NEW ENGLAND JOURNAL OF MEDICINE, 1990, 323 (19) :1289-1298
[4]   Insulin resistance and fat patterning with aging: Relationship to metabolic risk factors for cardiovascular disease [J].
Cefalu, WT ;
Werbel, S ;
Bell-Farrow, AD ;
Terry, JG ;
Wang, ZQ ;
Opara, EC ;
Morgan, T ;
Hinson, WH ;
Crouse, JR .
METABOLISM-CLINICAL AND EXPERIMENTAL, 1998, 47 (04) :401-408
[5]   Effects of high doses of simvastatin and atorvastatin on high-density lipoprotein cholesterol and apolipoprotein A-I [J].
Crouse, JR ;
Frohlich, J ;
Ose, L ;
Mercuri, M ;
Tobert, JA .
AMERICAN JOURNAL OF CARDIOLOGY, 1999, 83 (10) :1476-+
[6]  
Dean JD, 1996, DIABETIC MED, V13, P297, DOI 10.1002/(SICI)1096-9136(199604)13:4<297::AID-DIA82>3.0.CO
[7]  
2-Q
[8]   Hyperinsulinemia as an independent risk factor for ischemic heart disease [J].
Despres, JP ;
Lamarche, B ;
Mauriege, P ;
Cantin, B ;
Dagenais, GR ;
Moorjani, S ;
Lupien, PJ .
NEW ENGLAND JOURNAL OF MEDICINE, 1996, 334 (15) :952-957
[9]  
ESCHWEGE E, 1985, HORM METAB RES, V15, P41
[10]   SIMVASTATIN IN NON-INSULIN-DEPENDENT DIABETES-MELLITUS - EFFECT ON SERUM-LIPIDS, LIPOPROTEINS AND HEMOSTATIC MEASURES [J].
FARRER, M ;
WINOCOUR, PH ;
EVANS, K ;
NEIL, HAW ;
LAKER, MF ;
KESTEVEN, P ;
ALBERTI, KGMM .
DIABETES RESEARCH AND CLINICAL PRACTICE, 1994, 23 (02) :111-119